Carvedilol appears to protect against anthracycline-induced cardiomyopathy

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1569, 2007-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Developments in Anthracycline-Induced Cardiotoxicity

Current Medicinal Chemistry, Vol. 16, Iss. 13, 2009-05 ,pp. : 1656-1672

Bentham Science Publishers

Access to resources Recommend Favorite

BCG vaccination appears to protect against TB infection

Inpharma, Vol. 1, Iss. 1510, 2005-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

The mechanism for anthracycline-induced inhibition of collagen biosynthesis

By Muszynska A. Wolczynski S.b. Palka J.

European Journal of Pharmacology, Vol. 411, Iss. 1, 2001-05 ,pp. : 17-25

Elsevier

Access to resources Recommend Favorite

Anthracycline-Induced Cardiotoxicity in Children with Cancer: Strategies for Prevention and Management

By Iarussi Diana

Pediatric Drugs, Vol. 7, Iss. 2, 2005-01 ,pp. : 67-76

Adis International

Access to resources Recommend Favorite

Carvedilol superior to nebivolol for HF due to cardiomyopathy

Inpharma, Vol. 1, Iss. 1519, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite